_version_ 1784757129295429632
author Alkhateeb, Hassan B.
Mohty, Razan
Greipp, Patricia
Bansal, Radhika
Hathcock, Matthew
Rosenthal, Allison
Murthy, Hemant
Kharfan-Dabaja, Mohamed
Bisneto Villasboas, Jose C.
Bennani, Nora
Ansell, Stephen M.
Patnaik, Mrinal M.
Litzow, Mark R.
He, Rong
Chen, Dong
Al-Kali, Aref
Kenderian, Saad S.
Lin, Yi
Shah, Mithun Vinod
author_facet Alkhateeb, Hassan B.
Mohty, Razan
Greipp, Patricia
Bansal, Radhika
Hathcock, Matthew
Rosenthal, Allison
Murthy, Hemant
Kharfan-Dabaja, Mohamed
Bisneto Villasboas, Jose C.
Bennani, Nora
Ansell, Stephen M.
Patnaik, Mrinal M.
Litzow, Mark R.
He, Rong
Chen, Dong
Al-Kali, Aref
Kenderian, Saad S.
Lin, Yi
Shah, Mithun Vinod
author_sort Alkhateeb, Hassan B.
collection PubMed
description
format Online
Article
Text
id pubmed-9325766
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-93257662022-07-28 Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma Alkhateeb, Hassan B. Mohty, Razan Greipp, Patricia Bansal, Radhika Hathcock, Matthew Rosenthal, Allison Murthy, Hemant Kharfan-Dabaja, Mohamed Bisneto Villasboas, Jose C. Bennani, Nora Ansell, Stephen M. Patnaik, Mrinal M. Litzow, Mark R. He, Rong Chen, Dong Al-Kali, Aref Kenderian, Saad S. Lin, Yi Shah, Mithun Vinod Blood Cancer J Correspondence Nature Publishing Group UK 2022-07-26 /pmc/articles/PMC9325766/ /pubmed/35882844 http://dx.doi.org/10.1038/s41408-022-00707-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correspondence
Alkhateeb, Hassan B.
Mohty, Razan
Greipp, Patricia
Bansal, Radhika
Hathcock, Matthew
Rosenthal, Allison
Murthy, Hemant
Kharfan-Dabaja, Mohamed
Bisneto Villasboas, Jose C.
Bennani, Nora
Ansell, Stephen M.
Patnaik, Mrinal M.
Litzow, Mark R.
He, Rong
Chen, Dong
Al-Kali, Aref
Kenderian, Saad S.
Lin, Yi
Shah, Mithun Vinod
Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma
title Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma
title_full Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma
title_fullStr Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma
title_full_unstemmed Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma
title_short Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma
title_sort therapy-related myeloid neoplasms following chimeric antigen receptor t-cell therapy for non-hodgkin lymphoma
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325766/
https://www.ncbi.nlm.nih.gov/pubmed/35882844
http://dx.doi.org/10.1038/s41408-022-00707-4
work_keys_str_mv AT alkhateebhassanb therapyrelatedmyeloidneoplasmsfollowingchimericantigenreceptortcelltherapyfornonhodgkinlymphoma
AT mohtyrazan therapyrelatedmyeloidneoplasmsfollowingchimericantigenreceptortcelltherapyfornonhodgkinlymphoma
AT greipppatricia therapyrelatedmyeloidneoplasmsfollowingchimericantigenreceptortcelltherapyfornonhodgkinlymphoma
AT bansalradhika therapyrelatedmyeloidneoplasmsfollowingchimericantigenreceptortcelltherapyfornonhodgkinlymphoma
AT hathcockmatthew therapyrelatedmyeloidneoplasmsfollowingchimericantigenreceptortcelltherapyfornonhodgkinlymphoma
AT rosenthalallison therapyrelatedmyeloidneoplasmsfollowingchimericantigenreceptortcelltherapyfornonhodgkinlymphoma
AT murthyhemant therapyrelatedmyeloidneoplasmsfollowingchimericantigenreceptortcelltherapyfornonhodgkinlymphoma
AT kharfandabajamohamed therapyrelatedmyeloidneoplasmsfollowingchimericantigenreceptortcelltherapyfornonhodgkinlymphoma
AT bisnetovillasboasjosec therapyrelatedmyeloidneoplasmsfollowingchimericantigenreceptortcelltherapyfornonhodgkinlymphoma
AT bennaninora therapyrelatedmyeloidneoplasmsfollowingchimericantigenreceptortcelltherapyfornonhodgkinlymphoma
AT ansellstephenm therapyrelatedmyeloidneoplasmsfollowingchimericantigenreceptortcelltherapyfornonhodgkinlymphoma
AT patnaikmrinalm therapyrelatedmyeloidneoplasmsfollowingchimericantigenreceptortcelltherapyfornonhodgkinlymphoma
AT litzowmarkr therapyrelatedmyeloidneoplasmsfollowingchimericantigenreceptortcelltherapyfornonhodgkinlymphoma
AT herong therapyrelatedmyeloidneoplasmsfollowingchimericantigenreceptortcelltherapyfornonhodgkinlymphoma
AT chendong therapyrelatedmyeloidneoplasmsfollowingchimericantigenreceptortcelltherapyfornonhodgkinlymphoma
AT alkaliaref therapyrelatedmyeloidneoplasmsfollowingchimericantigenreceptortcelltherapyfornonhodgkinlymphoma
AT kenderiansaads therapyrelatedmyeloidneoplasmsfollowingchimericantigenreceptortcelltherapyfornonhodgkinlymphoma
AT linyi therapyrelatedmyeloidneoplasmsfollowingchimericantigenreceptortcelltherapyfornonhodgkinlymphoma
AT shahmithunvinod therapyrelatedmyeloidneoplasmsfollowingchimericantigenreceptortcelltherapyfornonhodgkinlymphoma